Board Certified Medical Affairs Specialist (BCMAS) Practice Exam

These questions are part of the practice quiz. Start practicing

• What safety measure should be put in place to avoid serious infection associated with a drug?
• What is a constraint on the manufacturing and selling of new medical devices?
• Which statement best describes the predicate device concept in device regulation?
• After sufficient safety and efficacy data exist for a new COVID-19 vaccine, which application is required to launch?
• Why is it important to consider patient values in evidence-based practice?
• Combination product applicant(s).
• Which statement best reflects policy on including off-label information in promotional materials?
• The third-tier compliance regulation 21 CFR Part 7 addresses what?
• Using a drug manual to answer a Medical Information question represents which level of evidence?
• Which statement best describes informative abstracts?
• Which option best represents an example of creating a healthcare policy document?
• In what year was the American Medical Writers Association (AMWA) established?
• Is it true or false that IIS grants can be awarded by professional societies?
• What can be both a challenge for advisory boards and a key element to a board's success?
• Which description best describes 21 CFR Part 211?
• Which drug description would be most likely to meet approval as a generic drug?
• Which content does molecular diagnostics primarily detect to understand disease pathogenesis?
• Which organization typically develops the communication plan?
• CRAMS service model emphasizes which of the following?
• Findings should be interpreted in the Results section.
• Bias is defined as which of the following?
• Not required by adverse drug reaction (ADR) reporting.
• What does the abbreviation CUA stand for in pharmacoeconomics?
• Which statement about storytelling in MSL/HCP interactions is most consistent with best practice?
• Which statement is not true about promotional materials?
• MSLs can aid in the design of corporate and investigator-initiated clinical trials.
• Which statement best describes continuing education (CE) programs in medical writing?
• Which advisory board has members with similar or relevant backgrounds?
• In vitro diagnostic test — example.
• In vitro describes something in glass such as a test tube or petri dish.
• Phase III trials are typically designed to assess effectiveness and safety in a larger patient population.
• What is a mobile medical application?
• In the clinical design stage, what is the most significant source of bias?
• Practicing a presentation beforehand should be avoided because it can lead to an overly rehearsed tone.
• Which regulatory classification applies to high-risk in vitro diagnostic devices requiring premarket approval?
• What term does the FDA use to describe a concern about an excess of adverse events compared to what would be expected with a product's use?
• Which CFR Part governs Good manufacturing practices for finished pharmaceuticals?
• What would cause the FDA to require post-marketing studies or clinical trials at the time of approval or afterwards for a new product?
• European clinical trials conducted to support drug approval are generally similar to those conducted in the United States.
• In the context of medical information, which professional is most likely to use a drug manual to craft a formal response to a question?
• Who should medication guides primarily communicate warnings or contraindications to?
• In research, which term describes distortion caused by other variables to both exposure and outcome?
• Which statement correctly contrasts CMA and CBA?
• Which distribution channels are regulated by the FDA?
• Which describes discounting in financial forecasting?
• 21 CFR Part 50 Subpart B addresses detailed requirements for which topic?
• Which scenario would most clearly violate the anti-kickback statute?
• Which study design is most commonly used in comparative research?
• What is the first step in conducting a pharmacoeconomic analysis?
• Which of the following is NOT a function of the Medical Communications Agency?
• What is the last step of practicing evidence-based medicine (EBM)?
• How have the Good Publication Practices (GPP) Guidelines for Sponsored Medical Research ensured industry standards?
• What is a primary way molecular diagnostics help understand disease pathogenesis at the molecular level?
• Which statement is true about public pharmaceutical companies?
• What is the correct order of the five major phases of drug development?
• Which testing can take place at the Pre-Clinical Research phase?
• Which study design assigns participants to two or more different treatment groups without randomization?
• Which of the following is regulated by the Office of Prescription Drug Promotion (OPDP)?
• What is a disadvantage of outsourcing in medical affairs?
• In Practice-Based Clinical Experience Studies (PESs), data are collected from which participants?
• NOT true about medical writers?
• Which act is most closely associated with drug labeling and promotion compliance?
• Which statement best describes pharmacovigilance's role in drug safety?
• Which of the following is NOT a typical reason for applying for a grant?
• What best describes a health status assessment?
• Which trait is commonly associated with high emotional intelligence?
• Which statement is true about the role of a KOL in publication development during a kick-off call?
• Indirect costs are best described as:
• What IVD market segment would Molecular Diagnostics belong to?
• Which of the following describes the Investigators Brochure?
• Cost-minimization analysis (CMA) is appropriate when which condition is met?
• When looking for research opportunities, you can use some Internet resources, such as:
• Fundamental requirement for ongoing risk evaluations of REMS.
• A meta-analysis is a type of study design that uses statistics to summarize results of several studies.
• ADR reporting is best described as:
• How often is the Development Safety Update Report (DSUR) typically submitted?
• Which statement about point-of-care diagnostics is false?
• What science is involved in the detection, assessment, and prevention of adverse effects in medicine?
• SADR reporting triggers post-marketing safety actions by the FDA.
• Under the second-tier regulations, which statement best describes 21 CFR Part 58 (subparts A-K)?
• Which law requires companies and manufacturers to publish their interactions with health care professionals?
• Which medication prompted the Kefauver-Harris Amendments?
• Direct medical costs are defined as which of the following?
• CRAMS service expansion: which option correctly identifies the full expansion?
• Which statement about FDA approvals for medical devices is true?
• FD&C Act is primarily associated with regulating which categories?
• Which statement aligns with the regulatory definition of a mobile medical application?
• A disadvantage of point-of-care diagnostics is training requirements.
• What type of measurements do diagnostic tests provide to ensure accurate and reliable delivery of information?
• Which option is not typically part of post-market safety monitoring?
• Which item is an example of a Class I medical device?
• Which statement best describes 21 CFR Part 58?
• For an advisory board developing a new medical device, which statement best captures its compliance focus?
• What best describes cost-minimization analysis (CMA)?
• What is the purpose of medication guides?
• Post-Marketing Requirements (PMRs) typically address what aspect?
• Which term describes the regulatory expectation that financial relationships with physicians be disclosed?
• In Khaled's 5-step process for responding to a Medical Information question, what is the third step he should follow?
• HR-QOL stands for which term?
• Which statement best describes the relationship between European and United States clinical trial processes?
• In the United States, which organization established voluntary codes and standards regarding ethical interactions between HCPs and pharmaceutical companies?
• Cost-minimization analysis (CMA) assumes that outcomes are equivalent.
• The European Union Reference Dates (EURD) is updated on an ongoing basis.
• Which A/B classification is an augmented pharmacologic effect that is dose dependent and predictable?
• What is the type of combination product in which the drug and device come in the same package as two different parts (e.g., a drug that comes with an empty syringe in the same package)?
• Which of the following is a potential disadvantage of IIS?
• Under the second-tier regulations, does the Institutional Review Board require a minimum of two members?
• In project management, the SMART paradigm stands for which elements?
• Which phase focuses on post-marketing research after a drug has been approved?
• Which statement accurately reflects company policy on promotional materials for MSLs?
• Which factor primarily determines the appropriate FDA approval pathway for a new medical device?
• What are some of the ways that companies can benefit from non-mandated Post-Marketing studies?
• Which statement about post-marketing trials is correct?
• Triad between manufacturers, HCPs, and consumers refers to which model?
• MSL teams can be as small as 1 or larger than 100 people.
• Which of the following is not one of the essential points to first consider when developing a medical affairs strategy?
• Off-label information solicited by a drug manufacturer violates which US federal act?
• Fellowship funding is best described as what type of grant?
• ETASU stands for which of the following?
• Which of the following is not typically part of PMCs?
• Which description best describes 21 CFR Part 210?
• 21 CFR Part 56 covers which regulatory topic?
• Who develops the clinical protocol for a study in a pharmaceutical company?
• What is the primary purpose of a communication plan in the context described?
• Which type of prescriber data includes information on how often a drug is prescribed?
• According to the PhRMA code, promotional materials provided to healthcare professionals by, or on behalf of a company should: Which statement is NOT a requirement?
• What term describes the packaging arrangement where a drug and a device come in the same package as two separate parts?
• Which statement about abstracts is true?
• Which description best fits a company that conducts research and manufactures drugs under licenses from other companies?
• Practice-Based Clinical Experience Studies (PESs) are:
• An advisory board moderator should develop which skill to keep meetings on track?
• In a setting with a standard of care for a serious illness, is it ethical to conduct a trial designed to demonstrate superiority over placebo?
• When considering interactions with healthcare professionals, the primary consideration should be the needs of whom?
• Which of the following regulates prescription drug promotional labeling?
• REMS are designed to address the ______ for different drugs and classes of drugs.
• In an equivalence trial, which hypothesis states that a difference of at least Δ exists?
• Which sequence correctly describes the typical regulatory submission flow for a drug in the United States?
• A kick-off call is a call in which the pharma company brings in the KOL (physician, nurse practitioner, pharmacist, etc.) who will collaborate in developing the publication.
• Which statement about abstracts presented at professional meetings is true?
• Which type of advertisement is required to provide a fair balance of drug risks compared with benefits?
• EBM databases are exemplified by which of the following?
• An MSL on your team provides a speaker honorarium in exchange for the healthcare provider to write at least 5 prescriptions per week of their newly approved drug. Which of the following is true?
• Which element is required in FDA labeling for in vitro diagnostic products?
• Which statement best describes a requirement of promotional materials under the PhRMA code?
• What is a study's perspective?
• Which of the following statements about Post-Marketing Research is NOT true?
• 21 CFR Part 50 focuses on:
• The EURD list pertains to the preparation of which type of report?
• Which of the following best defines the PICO constituents?
• The abbreviation BLA stands for what?
• Which phase focuses on testing in humans?
• Which section of a scientific manuscript should the inclusion/exclusion criteria fall under?
• Under the third-tier compliance regulations, which statement best describes 21 CFR Part 7?
• What forum, first hosted in the early 1980s by the WHO, is for global regulatory authorities to meet and discuss ways to strengthen collaboration?
• Which term in PICO describes the outcomes to be measured?
• The pharmaceutical industry's origins trace back to which country?
• Which type of economic analysis is used to compare costs and benefits by assigning a monetary value to all outcomes?
• Which PMCs study type is commonly used to observe real-world drug utilization patterns?
• Which analysis considers patient preferences in its outcome measures?
• Which type of advertisement is used to describe a disease without naming a drug?
• Jim's team plan with Key Opinion Leaders (KOLs) involves scheduling meetings. What type of product initiative is this?
• Non-randomized comparative studies are best described as which design?
• Diagnostic test data are characterized by which two properties?
• Which characteristic best describes descriptive abstracts?
• Which of the following best describes an appropriate educational gift for HCPs?
• Under which condition may a company use prescriber data? (NOT permissible use)
• What is an example of cost-effectiveness analysis (CEA)?
• Which statement about REMS design is correct?
• A kick-off call in publication development is typically described as:
• Which of the following is a tertiary source of evidence?
• Which statement best describes a benefit of interactions between pharmaceutical companies and health care professionals?
• Which set of outcomes is included in health outcomes research?
• What is the main purpose of an Investigational New Drug (IND) application?
• What is another name for a group allocation design?
• How long does it typically take for a person to form a first impression during an initial interaction?
• In DOTS classification, an adverse effect occurring at supratherapeutic concentrations is described as:
• In research investigations where the investigational product may offer a valuable treatment alternative, which trial designs can be used?
• In the context of post-marketing studies, what is the team’s role when a potential label change is identified?
• In clinical trials, which phase enrolls the largest number of participants?
• Prior to publication approval, which departments must approve abstracts, posters, oral presentations, and manuscripts?
• What did the Medical Device User Fees Amendment of 2012 authorize the FDA to do?
• Which regulatory concept describes the process that starts with an IND submission and ends with an NDA submission?
• Quality of Life (QOL) outcomes refer to the impact on a patient's overall well-being and daily functioning.
• In the 5-step process to respond to a Medical Information question, which step follows the initial assessment?
• Dr. Simpson, a neurologist, occasionally participates on an advisory board for Lightning Pharmaceuticals. Dr. Simpson has also just become a member of a national committee that makes recommendations for clinical guidelines and formulary decisions. Is Dr. Simpson required to disclose her relationship with Lightning Pharmaceuticals to the national committee she is a member of?
• Are IIS grant applications the same for all companies?
• Stephanie, a medical writer, is creating a descriptive abstract. Which of the following should she be sure to do so as to not confuse it with an informative abstract?
• Which best describes retrospective data?
• Which groups were mandated by the NIH Revitalization Act of 1993 to be included in clinical research?
• Which type of drug advertisement describes a disease but does not discuss a specific medication?
• Which type of medical writing involves creating continuing education programs for healthcare professionals?
• 21 CFR Part 58 governs what?
• CRAMS stands for which of the following?
• Which statement describes challenges around impact measurements using scholarly big data?
• Which item is NOT typically included in post-meeting follow-up communications?
• What is an example of secondary level of evidence?
• Which principle underpins truthful and balanced medical information communications?
• External validity refers to the extent to which study results can be generalized beyond the study sample.
• Which scenario best describes a proactive interaction between a pharma company representative and a healthcare professional?
• Which of the following is the first step in Ryan's grant process?
• IND stands for which of the following?
• Cost-benefit analysis (CBA) measures outcomes in what units?
• Which statement correctly describes when patent protection for a drug begins?
• Molecular Diagnostics belongs to which IVD market segment?
• What is considered the most challenging step when establishing an advisory board?
• Which statement describes an in vitro test environment?
• Which resource is an example of a place to locate clinical guidelines?
• Presentation skills are essential for maintaining a position with MA.
• A company modified a device that has FDA-established performance standards for the device and the modification already in place. Which FDA filing type should the company submit?
• What is the typical word limit for descriptive abstracts?
• What is the primary purpose of a Risk Evaluation and Mitigation Strategy (REMS) or Risk Management Plan (RMP)?
• What is an example of cost utility analysis (CUA)?
• Which REMS component is typically required to ensure safe use?
• Practice-Based Clinical Experience Studies (PESs) are designed to collect real-world data from which source?
• Which program requires companies to report certain payments to the federal government?
• In early drug development, what is the main purpose of consulting an advisory board?
• In pharmacoeconomic analyses, what does a sensitivity analysis examine?
• Which of the following is a type of prescriber data a company may use?
• The process of internal cooperation, coordination, and common standards across the global pharmaceutical industry is referred to as:
• What is the role of Medical Affairs in post-marketing studies?
• To ensure accurate data for a potential label change, the Medical Affairs team should:
• Can unapproved drug uses be included in SRDs?
• Which of the following statements about PMCs is true?
• Which is the chief consumer watchdog which assesses new drugs before they hit the market and continues to monitor safety after they are marketed?
• Which statement best describes descriptive abstracts?
• In health economics, which item is NOT a direct medical cost?
• An MSL delivers an educational program for cardiologists about a new cholesterol medication at a football game. Is this an appropriate interaction?
• Which act covers labeling and advertising of drugs in the United States?
• The medical affairs team contributes to the product launch by educating the medical community and customer groups.
• Amber is an MSL and receives a physician question about a medication indication that is not FDA approved. Which statement is true?
• The regulatory requirements for drug products include much tighter controls over the manufacturing process than for medical devices.
• Which option indicates the 2012 Medical Device User Fees Amendment aims to improve the overall review process?
• Which statement best reflects the purpose of post-marketing commitments?
• Which activity is typically described as part of the grant's pre-award phase?
• Goals of pharmacogenomics include which of the following?
• Which CFR Part covers Institutional Review Boards (IRB)?
• Primary literature is original research.
• Which statement about the PMA pathway for medical devices is true?
• CRAMS stands for which of the following expansions?
• Which term describes an unpleasant and unintended response to any dose of a drug or biologic product where there is a possibility that the product caused the response?
• Which resource is highlighted as a guide for locating guidelines?
• Which are the most important types of validity?
• Which of the following is NOT a purpose of IIS?
• Which agency administers the Physician Payments Sunshine Act reporting requirement?
• What type of educational gift would be considered appropriate for handing to a healthcare professional by a Medical Science Liaison?
• Which CFR Part corresponds to Quality and system regulations?
• CRAMS providers can best be described as entities that:
• Which of the following is an FDA labeling requirement for in vitro diagnostic (IVD) products?
• REMS may be required during which part of the product life cycle?
• When should companies start preparing for a product launch?
• Which statement is accurate about the advisory board's function?
• What is the Medical Device User Fees Amendment of 2012?
• What is the recommended timeframe for meeting follow-ups after the meeting?
• What does the 'P' in PICO stand for?
• Which CFR Part is titled 'human subjects protection'?
• In the 5-step process to respond to a medical information question, which step comes first?
• Which data type is most directly used to identify safety signals for regulatory action?
• Which statement accurately reflects the PICO framework structure?
• Which of the following best describes the purpose of an agenda and a meeting moderator for advisory board sessions?
• Which of the following is NOT a purpose of IIS?
• In cost-effectiveness analysis, which outcome measure is illustrated by the example comparing two drugs?
• Which of the following meal policies is considered appropriate when representatives interact with healthcare professionals?
• Which product was used as an obesity treatment and advertised on the radio without including adverse effects of tachycardia and insomnia?
• How are REMS designed to help drug sponsors?
• The publication plan is primarily used to do what?
• What term describes the bias when the enrolled cohort differs from the general population?
• Which statement about FDA clearance for medical devices is true?
• An example of a marketed product SRD is:
• What is the first step of practicing evidence-based medicine (EBM)?
• Randomized controlled trials usually have more bias than non-randomized controlled trials.
• What is the purpose of the Investigators Brochure?
• True or False: The use of storytelling in MSL/HCP interactions is outdated and should be avoided.
• Approximately how many articles about COVID-19 were published in 2020?
• Which limitation is commonly associated with systematic reviews?
• During which phase of the drug development process does testing in humans begin?
• ETASU statement: 'Elements to Assure Safe Use' are required medical interventions taken by HCPs prior to using the drug.
• When would a New Drug Application (NDA) be submitted?
• Compared with generic HR-QOL instruments, disease-specific instruments are more likely to
• Under 21 CFR Part 211 Subpart A, what best describes its purpose?
• Which technology or approach enables the identification of patient responders in rare diseases, supporting diagnostic expansion?
• In cost-utility analysis, which outcome measure is typically used?
• What is a typical discount rate range used in pharmacoeconomic analyses?
• Which are considered key items the FDA will contemplate when deciding on whether REMS is needed?
• When answering a medical information question, which step involves assessing the credibility and relevance of the information source?
• Which factor considers the extent to which a reaction can cause harm?
• Post-marketing trials involve fewer patients than Phase III studies.
• The Prescription Drug Marketing Act allows drug samples to be provided for patient use.
• The Medical Dictionary for Regulatory Activities (MedDRA) and the Common Technical Document (CTD) were developed through the work of which organization?
• Which type of application do you need to file with the FDA to obtain approval to initiate clinical trials?
• Which statement about post-marketing data collection is true?
• In the described market model, who functions as the important middlemen between manufacturers and consumers?
• Which description best summarizes 21 CFR Part 211 (subparts A-K)?
• What fraction of communication is typically conveyed by tone of voice in professional interactions?
• In a proactive interaction, who initiates the discussion about product information?
• An abbreviated new drug application is submitted to the FDA for which products?
• Which option best completes this statement: The goal of evidence-based medicine is to integrate best research evidence with clinical expertise and patient values?
• Which study design is classified as retrospective?
• What ratio of content to interactivity should you strive to maintain in a presentation?
• Which step involves deciding on the best source to answer the question?
• Which reason explains why Medical Science Liaisons (MSLs) may gain access to a physician's time more readily than traditional drug sales representatives?
• Manufacturers are not required to report serious adverse events to the FDA.
• Which of the following is not a component of the SMART paradigm for goals?
• In promotional content, the term 'off-label indications' refers to uses not approved by the FDA.
• What must the label of a companion diagnostic device contain information about?
• Which of the following studies is NOT typically included as part of Post-Marketing Commitments (PMCs)?
• Before market approval, testing for medical devices typically includes which set of attributes?
• When would an Investigational New Drug Application (IND) be submitted?
• Health outcomes research encompasses pharmacoeconomic outcomes, therapeutic outcomes, nontherapeutic outcomes, and which other type?
• Which of the following is NOT typically included in the Drug Discovery Stage approaches?
• Which of the following is a goal of pharmacogenomics?
• In cost-effectiveness analysis, which is a common outcome measure?
• Which professional typically answers Medical Information questions by consulting drug references?
• A medical device company has completed form, fit, function, and safety testing but the device has no predicate device on the market and is presumed safe. Which FDA device class should be used to determine the appropriate approval process?
• For marketing a biologic product in the United States, which regulatory submission is required?
• Which phase typically follows the discovery phase?
• Which statement about companion diagnostic labeling is true?
• The study of variations in DNA and RNA characteristics as related to drug response
• Which term describes the science that explains how inherited genetic differences influence individual responses to medications?
• What is Pharmacoeconomics?
• Post-Marketing Commitments (PMCs) include study designs not mandated by the FDA.
• A newly approved pacemaker is undergoing ongoing surveillance for concerns. Which step of device development does this represent?
• Audience members come to a presentation with the primary focus of, "what's in it for me"?
• Which phase involves post-approval studies and ongoing safety assessment?
• Who is required to submit a periodic safety update report?
• Prior to publication approval, which departments typically approve abstracts, posters, oral presentations, and manuscripts?
• Why would a pharma company consult an advisory board when starting development of a new drug?
• Which statement best describes primary literature?
• Retrospective data are used to estimate costs for which period?
• First step of the process for device development?
• In the 5-step process to respond to a medical information question, which step is the final step?
• What is the first step to initiate the grant process?
• Under the first-tier compliance regulations, which statement best describes 21 CFR Part 211 (subparts A-K)?
• Under what conditions can a pharma company provide financial support for conferences and CME?
• At what point in the drug development process can a product launch occur?
• Which of the following helps ensure that prescription drug promotion is truthful, balanced, and accurate?
• Which advisory board is composed of up to 15 members with different backgrounds for a large-sized company?
• What is the likely impact of outsourcing on workflow consistency?
• In a randomized trial, which statement best describes the role of randomization?
• Which term describes the ongoing collection of data on the safety of medicines after they've been marketed?
• Over a 10-year timeframe as of July 2020, approximately how many reports of potentially false or misleading promotion were submitted by healthcare professionals to the Bad Ad Program?
• Which statement about the Office of Prescription Drug Promotion (OPDP) is accurate?
• Post-Marketing Trials may be more complicated and time consuming than Phase III Clinical Trials. Which option is correct?
• Which item is NOT commonly considered by the FDA when deciding on REMS?
• Which statement best describes evidence-based medicine?
• Which statement is NOT a stated benefit of interactions between pharmaceutical companies and health care professionals?
• Which law requires manufacturers to demonstrate that drugs are safe and effective before marketing?
• Which section of the Code of Federal Regulations (21 CFR) covers the procedures for performance standards development?
• Which of the following best describes the content of systematic reviews?
• What is the scientific platform?
• When first working on a publication, what should authors do to identify their rights, roles, and responsibilities?
• Are surveys classified as cross-sectional studies?
• Which drug type has risks that may not be well understood?
• Which statement about the FDA 510(k) clearance pathway is accurate?
• In clinical research, which term best represents the ratio of the odds of developing the outcome in the exposed group to the odds in the unexposed group?
• Which of the following is a secondary literature source?
• Are published abstracts required to follow a defined structure or guidelines for publication purposes?
• As an MSL, if asked to influence grant planning content, what is the appropriate response?
• Which term describes an advisory board where members share similar backgrounds?
• Among the four types of presenters in the context of MSL work, which should be the goal of an MSL professional?
• Product Lifecycle Management (PLM) is described as the process of managing the lifecycle of a product (a drug) from innovation, development, and introduction to withdrawal from the market.
• Which agency is a primary regulator of pharmaceuticals in the United States?
• What does REMS stand for?
• What is the primary goal of medical affairs?
• What is outcomes research?
• Which statement best describes a disease-specific Health-Related Quality of Life instrument?
• Which element is NOT necessary for the REMS of the Abbreviated New Drug Application (ANDA)?
• Which statement best describes outcomes research focus?
• The NIH Revitalization Act of 1993 directed the NIH to include which groups in clinical research?
• T/F: Medical information responses must be specific, scientifically objective, balanced, truthful, transparent, and non-misleading.
• Which statement best describes the purpose of post-marketing studies?
• Which of the following is an essential compliance consideration for an advisory board on a new medical device?
• Which statement best describes post-marketing trials?
• Individual board members are known as:
• IRB subpart addresses which element?
• Who submits reports to the FDA's Bad Ad Program?
• The medical director analyzes the data and determines whether there are informational gaps.
• Which element is included in REMS to ensure safe use?
• Which statement would best describe the purpose of a health status assessment instrument?
• What type of study best provides real-life feedback from practitioners who have exposed a drug to a large number of patients?
• Approximately how many slides should a 15 minute presentation include?
• Which database is known for systematic reviews and meta-analyses in healthcare?
• In preparing a grant proposal, which item is NOT typically included?
• What is the ethical obligation for a clinician who has financial ties to a pharmaceutical company and serves on a clinical guidelines committee?
• Which question best captures the aim of practicing evidence-based medicine?
• Best practice and ethical standards for reporting research published in medical journals.
• Which economic challenge is commonly faced by medical device manufacturers?
• Statement: Medical writers should address the public's questions to prevent the spread of health misinformation.
• What is a common cause of export challenges for a medical device company?
• If a study does not require a mean and variance, what type of distribution is most likely indicated?
• What is an example of primary level of evidence?
• Why is the diagnostic industry expanding its focus to rare diseases?
• Which activity is a core function of pharmacovigilance?
• During which phase of the research process do MSLs typically begin surveillance of a specific therapeutic area or compound?
• Which role is primarily responsible for ongoing pharmacovigilance and adverse event reporting within a pharmaceutical company?
• In the described Phase III trial comparing osamarin to losartan, what type of study is it?
• Which term is NOT a component of PICO?
• New drug indications, new product combinations, new routes of administration, new drug delivery formulations, and testing of new excipients can all be:
• Which of the following is a recommendation from the GPP guidelines?
• What does the acronym PMR stand for?
• In grant management, which stage is focused on reviewing, assessing, and auditing information?
• In cost-effectiveness analysis, which type of outcome is used?
• The key to maintaining the integrity of and trust in medical communication is _________?
• Severe birth defects are not included in FDA mandated REMS.
• Which statement describes the purpose of the FDA's Bad Ad Program?
• In pharmacovigilance, safety signals are identified against a background of what?
• SRDs are prepared for which audiences?
• Pre-test and post-test studies determine the changes before and after the intervention.
• True or False: The primary function of an advisory board is to offer trusted advice on the company's issues.
• In a parallel study design, how are participants allocated to interventions?
• CRAMS service mix includes both research and manufacturing capabilities. Which option best describes this?
• What percentage of communication meaning is derived from words?
• Medical Information usually provides data-driven, targeted, and fair-balanced drug information for HCPs in which phase?
• Which step of the device development process involves the product launch and post-market safety monitoring?
• A regulator's decision to approve a drug for marketing is based on it having a ______ of benefits and risks within the conditions specified in the product labeling.
• To what agency/organization must companies and manufacturers report payments to physicians, investment interests held by physicians, and transfers of value made to physician owners?
• The first step in initiating research funding involves which activity?
• In the PICO approach to practicing evidence-based medicine, what does the 'I' stand for?
• A medical science liaison is tasked with creating a slide deck for a medical conference for physicians. The target audience is physicians.
• 21 CFR Part 820 governs which area?
• REMS are designed to address the ______ for different drugs and classes of drugs.
• When were the first Good Pharmaceutical Practice guidelines published?
• Which statement best describes a sensitivity analysis in pharmacoeconomic evaluations?
• In regulatory terms, what does the phrase 'satisfactory balance' refer to?
• Which statement best describes the investigator's responsibilities in a regulatory environment?
• Which of the following is a reason for conducting Post-Marketing studies?
• What is the integration of the best research evidence with clinical expertise and patient values called?
• Which description best aligns with compliant meals during representatives' interactions with healthcare professionals?
• What are bibliometrics designed to provide?
• Which statement describes the content typically found in an informative abstract?
• Which of the following lists contains the three main literature classifications?
• The statement 'Under the second-tier compliance regulations, 21 CFR Part 50 Subpart B addresses detailed requirements for informed consent' is true.
• Which organization is responsible for harmonizing regulatory standards in the pharmaceutical industry?
• At what point in a drug's lifecycle does the 20-years of patent protection begin?
• Which acronym stands for International Conference of Drug Regulatory Authorities?
• A group allocation design is also known as cluster randomization.